Legal Issues

For-profit dialysis centers used more dangerous drugs

An analysis of for-profit kidney dialysis centers published in the medical journal JAMA Internal Medicine found that they used more of an expensive and dangerous class of drugs known as erythropoiesis-stimulation agents (ESAs) than non-profit facilities.

This isn’t the first time that commercial dialysis centers have been accused of engaging in unsafe practices.

The U.S. Food and Drug Administration is investigating allegations that Fresenius, a German company that is the largest operator of ...

continue reading...

Diabetes experts support Byetta, Januvia critic

A number of the world’s top diabetes experts agree with Dr. Peter C. Butler, an internationally renowned physician who raised alarms about the diabetes drugs Januvia and Byetta.

A story on MedPage Today quotes Andrew Boulton, MD, president of the European Association for the Study of Diabetes (EASD), as saying that he has the “highest respect for Peter Butler as a colleague, clinician and scientist.”

The New York Times recently ran a profile ...

continue reading...

Company pleads guilty to drug safety violations

Ranbaxy, a subsidiary of Japanese pharmaceutical company Daiichi Sankyo, has pleaded guilty to drug safety violations. According to a story in the New York Times, the company will pay $500 million in fines over allegations that it sold subpar drugs.

Company officials also allegedly made false statements to the U.S. Food and Drug Administration about manufacturing practices at two factories in India.

Daiichi Sankyo has faced other allegations recently concerning its medications.

Two clinical ...

continue reading...

Another IUD approved for Bayer

Reuters reports on a recently approved intrauterine device from Bayer, which is the first new device of its type that the FDA has approved in 12 years.

According to the report, the new IUD is called Skyla. It’s a T-shaped polyethylene device that prevents pregnancy by releasing low doses of the hormone progestin.

Bayer manufactures another IUD available on the U.S. market called Mirena. But where Mirena is designed for use by women ...

continue reading...

Report: Byetta, Januvia, makers downplayed risk of pancreatic cancer

The prestigious medical journal BMJ has published a damning investigative article on a crop of new diabetes drugs called “incretin therapies,” which include Byetta and Januvia.

The article mentions a number of studies that have been published in recent years, indicating a potential link between these drugs and a potentially deadly inflammation of the pancreas called pancreatitis, as well as pancreatic cancer. Byetta has also been linked to thyroid cancer.

But the BMJ ...

continue reading...

Man with traumatic brain injury awarded settlement

According to British newspaper the Mansfield and Ashfield Chad, a 26-year-old man left disabled from birth because of a traumatic brain injury has successfully sued for damages.

Although the amount is undisclosed, the story says the equivalent of millions of dollars have been awarded in similar cases.

The man’s mother filed the lawsuit on his behalf. According to the story, he was deprived of oxygen during his birth at King’s Mill Hospital in ...

continue reading...
Page 6 of 64 «...45678...»